Highlight
- Medicaid expansion (ME) under the Affordable Care Act is linked with a significant reduction in 3-year disease-specific mortality among patients under 65 years diagnosed with colorectal cancer and synchronous liver metastasis (CRLM).
- The mortality benefit was most pronounced in patients undergoing liver metastasectomy, suggesting improved access to complex multidisciplinary surgical and systemic oncologic care.
- Decreased mortality was observed starting 2-3 years after Medicaid expansion and persisted beyond 6 years, despite no significant increase in liver surgery rates.
- ME may enhance continuity and quality of complex cancer care by facilitating access to systemic therapies and multidisciplinary management in populations historically underserved.
Specialty calculators
For clinical reference; use professional judgment.

